Ikarian Capital, LLC
Q3 2026 13F-HR Holdings
Net value change ($000)
+65,980
(7.1%)
New positions
19
Sold out positions
20
Turnover %
19.8%
Sector allocation + QoQ delta (equities-only)
Snapshot: Change Analysis
Compared to Q2 2026
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| AMLX | 14,228 | 674.3% |
| KOD | 9,252 | 22.4% |
| ORIC | 7,042 | NEW |
| DAMORA THERAPEUTICS INC | 5,867 | NEW |
| FREENOME INC | 5,711 | NEW |
| PHVS | 5,255 | 49.2% |
| HELP | 5,118 | 585.6% |
| SNSE | 5,054 | 571.1% |
| IMNM | 4,859 | 382.3% |
| VOR | 4,770 | NEW |
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000):
490,041
(49.3% of total reported value)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|